1-deoxynojirimycin has been researched along with Parkinsonian Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Fischer, D; Andreas, H; Hirsch, EC; Höglinger, GU; Höllerhage, M; Lu, L; Noelker, C; Oertel, WH; Roscher, R; Sturn, A; Vulinovic, F | 1 |
| Goker-Alpan, O; Sidransky, E | 1 |
| Belmatoug, N; de Villemeur, TB; Stirnemann, J | 1 |
3 other study(ies) available for 1-deoxynojirimycin and Parkinsonian Disorders
| Article | Year |
|---|---|
Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease.
Topics: 1-Deoxynojirimycin; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Cell Count; Cells, Cultured; Disease Models, Animal; Embryo, Mammalian; Gaucher Disease; Glycoside Hydrolase Inhibitors; Histocompatibility Antigens; Inositol; L-Lactate Dehydrogenase; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Mitochondrial Diseases; Neurons; Parkinsonian Disorders; Tyrosine 3-Monooxygenase | 2015 |
Treating patients with Gaucher disease and parkinsonism: misrepresentation in a title.
Topics: 1-Deoxynojirimycin; Aged; Enzyme Inhibitors; Gaucher Disease; Humans; Male; Parkinsonian Disorders | 2008 |
[Organization of Gaucher disease management in France].
Topics: 1-Deoxynojirimycin; Adolescent; Adult; Aged; Child; Child, Preschool; Enzyme Inhibitors; Female; France; Gaucher Disease; Glucosylceramidase; Hospitalization; Humans; Infant; Infant, Newborn; Male; Middle Aged; Parkinsonian Disorders; Registries; Saposins; Treatment Outcome | 2007 |